These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30655904)

  • 21. Comparison of Adjuvant Chemotherapy for Upper Tract versus Lower Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Jazayeri SB; Liu JS; Weissman B; Lester J; Samadi DB; Feuerstein MA
    Curr Urol; 2019 Jul; 12(4):177-187. PubMed ID: 31602183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort Study.
    Hongda Z; Kang L; Ng CF; de la Rosette J; Laguna P; Gontero P; Baard J; Yildiz O; Teoh JY
    Bladder Cancer; 2023; 9(3):217-226. PubMed ID: 38993186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract.
    Jwa E; Kim YS; Ahn H; Kim CS; Lee JL; Kim SO; DO Ahn S
    Anticancer Res; 2014 Jan; 34(1):333-8. PubMed ID: 24403484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.
    Zalay O; Yan M; Sigurdson S; Malone S; Vera-Badillo FE; Mahmud A
    Curr Oncol; 2022 Dec; 30(1):19-36. PubMed ID: 36661651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.
    Duplisea JJ; Petros FG; Li R; Fellman B; Guo CC; Czerniak BA; Siefker-Radtke AO; Araujo JC; Dinney CPN; Matin SF
    Urol Oncol; 2019 Jun; 37(6):354.e19-354.e26. PubMed ID: 30777393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma.
    Lin WY; Lin MH; Yang YH; Chen WC; Huang CE; Chen MF; Wu CT
    Front Surg; 2022; 9():903123. PubMed ID: 35693310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis.
    Qiu D; Hu J; He T; Li H; Hu J; Yi Z; Chen J; Zu X
    Transl Androl Urol; 2020 Oct; 9(5):2094-2106. PubMed ID: 33209672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
    Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
    BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
    Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
    World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
    Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
    Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective controlled observation ofeffect of adjuvant chemotherapy onsurvival and prognosis ofhigh-risk upper tract urothelial carcinoma patients underwent radical nephroureterectomy].
    Luo Y; Feng BF; Wei DC; Han YL; Li MC; Zhao JH; Lin YH; Li Q; Hou Z; Zhang GY; Jiang YG
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3158-3163. PubMed ID: 31694107
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma.
    Huang YC; Chang YH; Chiu KH; Shindel AW; Lai CH
    Sci Rep; 2016 Dec; 6():38175. PubMed ID: 27910890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
    Kim HS; Lee JS; Jeong CW; Kwak C; Kim HH; Ku JH
    Int Braz J Urol; 2015; 41(6):1067-79. PubMed ID: 26742963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Seisen T; Krasnow RE; Bellmunt J; Rouprêt M; Leow JJ; Lipsitz SR; Vetterlein MW; Preston MA; Hanna N; Kibel AS; Sun M; Choueiri TK; Trinh QD; Chang SL
    J Clin Oncol; 2017 Mar; 35(8):852-860. PubMed ID: 28045620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
    BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis.
    Chen L; Ou Z; Wang R; Zhang M; He W; Zhang J; Zu X; Yi L; Xu R; Jiang S; Qi L; Wang L
    Ann Surg Oncol; 2020 Apr; 27(4):1297-1303. PubMed ID: 31853757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.